Caricamento...
No effect of low-dose statins treatment on cerebral blood flow in humans with atherosclerotic cerebrovascular disease
Animal studies have suggested that the reduction in stroke risk observed with 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) therapy is owing to an increase in basal cerebral blood flow (CBF). The purpose of the study was to determine if statin therapy was associated...
Salvato in:
| Autori principali: | , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2007
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2680545/ https://ncbi.nlm.nih.gov/pubmed/17356563 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.jcbfm.9600469 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|